Urotronic Inc.
Clinical trials sponsored by Urotronic Inc., explained in plain language.
-
New device tested for common prostate problem
Disease control Recruiting nowThis study is checking the safety and effectiveness of the Optilume BPH Catheter System, a device used to treat symptoms of an enlarged prostate. It will involve 92 men aged 50 and older who have bothersome urinary symptoms. Researchers will track how well the device relieves sym…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Apr 04, 2026 00:20 UTC
-
New balloon device aims to keep ureters open, reduce repeat surgeries
Disease control Recruiting nowThis study is testing a new device called the Optilume Drug-Coated Balloon to treat ureteral strictures, which are narrowings in the tube that carries urine from the kidney to the bladder. The main goal is to see if using this balloon, which is coated with a drug called paclitaxe…
Phase: NA • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
New catheter treatment aims to tame troublesome prostate symptoms
Disease control Recruiting nowThis study is creating a registry to track the real-world results of a treatment called the Optilume BPH Catheter System. It will follow 500 men who have already received this treatment for their symptomatic enlarged prostate (BPH). The main goal is to see how much their urinary …
Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
Doctors track sperm health after common Men's procedure
Disease control Recruiting nowThis study is checking if a treatment for a narrowed urethra (a tube in the penis) affects a man's sperm. It will follow 34 men for up to a year after they get the Optilume treatment. The main goal is to see if sperm concentration changes at 3 and 6 months after the procedure.
Phase: PHASE4 • Sponsor: Urotronic Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC